ΔΎΉΟΦ±²₯

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

Benefits of Transplant for Pediatric Sickle Cell Disease Add Up a Decade Later

β€” Better disease outcomes, measures of cognition, and quality-of-life vs standard care, study finds

4 Hrs Ago
ASH over a photo of San Diego Convention Center

Latest in Oncology/Hematology

Transplantation Fails to Improve Survival in Mantle Cell Lymphoma

New standard of care for patients in first remission?

4 Hrs Ago
Lentiviral Gene Therapy Shows Promise in Severe Hemophilia A

Increased factor VIII levels to mild or moderate range, with annualized bleeding rate of zero

4 Hrs Ago
Year in Review: Chronic Lymphocytic Leukemia

Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more

5 Hrs Ago
Year in Review: Chronic Lymphocytic Leukemia

Top news in 2024 included the first CAR-T approval for CLL, triplet regimens, and more

Oncology/Hematology Case Studies

Middle-Age Man Presents With Necrotizing Mass on Nose

Rare condition can be deadly without early diagnosis and treatment

 A photo through the doorway of the CT scanning room.
Significant Left Nasal Obstruction Finally Diagnosed After 2 Years

Nonspecific presentation impedes early diagnosis of rare indolent tumor in older man

A female ear, nose, and throat doctor wearing a headlamp examines her senior male patient.
After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms

Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge

A photo of a woman’s hand on her skin, which is affected by a rash.

More in Oncology/Hematology

Hydroxyurea Shows Some Benefits in Milder Sickle Cell Disease

Treatment tied to fewer vaso-occlusive pain events, hospitalizations versus placebo

Dec 09, 2024
ASH over a photo of San Diego Convention Center
Fixed-Duration Oral Doublet for Fit CLL Wins in Frontline Setting

AMPLIFY trial paves the way for FDA approval of acalabrutinib plus venetoclax

Dec 09, 2024
ASH over a photo of San Diego Convention Center
Treatment of Smoldering Myeloma Cuts Progression Rate in Half

Daratumumab significantly improved PFS, OS, but identity of high-risk population remains elusive

Dec 09, 2024
ASH over a photo of San Diego Convention Center
Promising Results With Epcoritamab Monotherapy in Relapsed/Refractory CLL

Complete responses seen in 43% of patients in expansion cohort of EPCORE CLL-1 study

Dec 08, 2024
ASH over a photo of San Diego Convention Center
Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia

Rilzabrutinib specifically designed to reduce platelet-targeting autoantibodies

Dec 08, 2024
ASH over a photo of San Diego Convention Center
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma

Two-thirds of phase II patients had a complete response at 12 weeks of treatment

Dec 08, 2024
ASH over a photo of San Diego Convention Center
Dietary Intervention Shows Promise in Blood Cancers

High-fiber diets tied to improved outcomes in stem-cell transplants, slowing myeloma precursors

Dec 08, 2024
ASH over a photo of San Diego Convention Center
Texting to Improve Adherence to CVD Medications; Detecting Maternal Cancers

Also in TTHealthWatch: U.S. drug prices under Medicare's price negotiation system

Dec 07, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL

Cytokine release syndrome developed in all patients, including grade 3/4 events in nearly half

Dec 07, 2024
ASH over a photo of the San Diego Convention Center
New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia

Blinatumomab consolidation reduced risk of relapse by 61% versus chemotherapy alone

Dec 07, 2024
ASH over a photo of San Diego Convention Center
Eltrombopag Improves Outcomes in Kids With Newly Diagnosed ITP

Drug may potentially "transform" approach to upfront treatment, investigator says

Dec 07, 2024
ASH over a photo of San Diego Convention Center
Experts Wrestle Over Uses of PFAS During Senate Hearing

Industry witness warns of unintended consequences of blanket bans

Dec 06, 2024
A screenshot of Senator Jeff Merkley speaking during this hearing.
Self-Pay, AI-Enhanced Breast Cancer Screening Detected More Cancers

Overall cancer detection rate was about 43% higher versus women who chose not to participate

Dec 06, 2024
RSNA over a photo of McCormick Place in Chicago, IL.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

News, features, and commentary about cancer-related issues

Dec 05, 2024
Onco Break over a computer rendering of a cancer cell.
More in Oncology/Hematology

Latest Meetings